2616 — CStone Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for CStone Pharmaceuticals, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,726	1,042	1,027	673	919
Net Total Accounts Receivable
Net Total Receivables	118	77.1	172	83.9	33.8
Total Inventory
Total Other Current Assets
Total Current Assets	1,958	1,247	1,330	1,090	1,113
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	188	207	153	131	83.1
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,271	1,638	1,662	1,393	1,358
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	933	946	850	682	510
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1,064	1,189	1,205	1,030	742
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,207	449	457	364	617
Total Liabilities & Shareholders' Equity	2,271	1,638	1,662	1,393	1,358
Total Common Shares Outstanding